Stay updated on HIV+ Safety of High-dose Rifapentine-Isoniazid DDI Clinical Trial

Sign up to get notified when there's something new on the HIV+ Safety of High-dose Rifapentine-Isoniazid DDI Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the HIV+ Safety of High-dose Rifapentine-Isoniazid DDI Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.4 to v3.6.5, representing a small backend/content management update.
    Difference
    0.1%
    Check dated 2026-08-08T18:29:47.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    The page’s revision metadata updated from v3.6.3 to v3.6.4, indicating a new version of the page.
    Difference
    0.1%
    Check dated 2026-07-25T11:40:21.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.2 to v3.6.3, reflecting a minor update to the study record documentation.
    Difference
    0.1%
    Check dated 2026-07-03T23:54:20.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The revision tag in the page footer was updated from v3.6.0 to v3.6.2, indicating a newer platform release.
    Difference
    0.1%
    Check dated 2026-06-26T22:31:40.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    Recruitment status is updated to indicate enrollment is closed. New help pages and navigation tools were added to guide users on reading the study record and joining, with a formatting update to the Intervention/Treatment label.
    Difference
    0.4%
    Check dated 2026-06-12T16:09:06.000Z thumbnail image
  9. Check
    80 days ago
    Change Detected
    Summary
    Revision label updated to v3.5.5, replacing the previous v3.5.4 in the page history. This indicates a new page revision was published, likely for minor editorial updates.
    Difference
    0.1%
    Check dated 2026-06-05T10:37:08.000Z thumbnail image

Stay in the know with updates to HIV+ Safety of High-dose Rifapentine-Isoniazid DDI Clinical Trial

Enter your email address, and we'll notify you when there's something new on the HIV+ Safety of High-dose Rifapentine-Isoniazid DDI Clinical Trial page.